Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers
AI drug development startup Pathos AI closes $237M investment
Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers.
S
Maria Deutscher · via SiliconANGLE AI
Curated & Verified Aggregation
Friday, October 23, 2026
2 min
Original reporting by SiliconANGLE AI
Read the full story at SiliconANGLE AIListen to this story
Narrated edition • 2 min read time
Related Stories
industryaitalky dispatch
“OpenAI says it will no longer train its AI models on the live internet, citing "significant risks"”
via TechCrunch AIPRIMARY SOURCE
OpenAI says it will no longer train its AI models on the live internet, citing "significant risks"
industryaitalky dispatch
“Hottest toy for Christmas? Nvidia CEO plays with adorable Microduck robots, 20,000 sell”
via TechCrunch AIPRIMARY SOURCE
Hottest toy for Christmas? Nvidia CEO plays with adorable Microduck robots, 20,000 sell
